Surgery Partners (SGRY) Stock Analysis & AI Equity Report

Medical - Care Facilities USD Explore free reports

Surgery Partners (SGRY) overview

Surgery Partners (SGRY) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 3,309m and operating profit of USD 390m; the year-end share price was 15.45 USD and market capitalisation was USD 1,998m. Surgery Partners is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Surgery Partners's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 1,713mFY 2025
Share price15.45 USDFY 2025 year end
RevenueUSD 3,309mFY 2025
Operating profitUSD 390mFY 2025
Net earningsUSD -77.9mFY 2025
Market capitalisationUSD 1,998mFY 2025 year end

About Surgery Partners

Surgery Partners owns and operates surgical facilities and related healthcare services through subsidiaries. Its operations include ambulatory surgery centers, short stay surgical hospitals, anesthesia services, urgent care facilities, and multispecialty physician practices. Facilities provide planned, primarily nonemergency procedures across specialties such as orthopedics, ophthalmology, gastroenterology, pain management, and general surgery, serving patients and physicians in outpatient care.

Generate the Surgery Partners report

Surgery Partners is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Surgery Partners and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Surgery Partners

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.